CHROMOGENICS RESOLVES ON A RIGHTS ISSUE OF APPROXIMATELY SEK 30 MILLION AND BRINGS FORWARD THE ANNUAL GENERAL MEETING AND ANNUAL REPORT FOR 2022
PRESS RELEASE THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH ACTIONS, WHOLLY OR IN PART, WOULD BE SUBJECT TO LEGAL RESTRICTIONS. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO BUY SECURITIES IN CHROMOGENICS AB. SEE ALSO THE SECTION “IMPORTANT INFORMATION” BELOW.The board of directors of ChromoGenics AB ("ChromoGenics" or the "Company") has today, on 17 May 2023, resolved, subject to